1. National Library of Medicine (US). Familial lipoprotein lipase deficiency.
https://ghr.nlm.nih.gov/condition/familial-lipoprotein-lipase-deficiency#statistics
. Accessed 14 Mar 2017.
2. Gaudet D, Methot J, Dery S, Brisson D, Essiembre C, Tremblay G, Tremblay K, de Wal J, Twisk J, van den Bulk N, et al. Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial. Gene Ther. 2013;20:361–9.
3. Brunzell JD. Familial lipoprotein lipase deficiency. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]; 1999.
https://www.ncbi.nlm.nih.gov/books/NBK1308/
. Accessed 14 Mar 2017.
4. Office of National Statistics. Population estimates for UK, England and Wales, Scotland and Northern Ireland: mid-2015. Published June 2016.
https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/bulletins/annualmidyearpopulationestimates/mid2015
. Accessed 14 Mar 2017.
5. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res. 1996;37:693–707.